BioClever was created as a stand-alone organization in 2005. Until then, BioClever was part of the Biomedical Systems Group, and later Quintiles. Through national and international agreements, in 2005 BioClever was established as an independent CRO offering a full range of services for comprehensive project development. In 2006, we pledged our firm commitment to our working methodology and decided to manage all our studies and clinical trials with the quality that only internationally-renowned tools could ensure. So began our collaboration with Clinsight.

Clinsight is an integrated on-line platform providing comprehensive solutions for the global management of any type of project at any level—study oversight, data management, monitoring, etc. Clinsight covers any adaptation needs required for a particular project design. The Clinsight platform complies with all international standards (FDA, 21CFR Part 11 and ICH Guidelines) on clinical trial conduct and management. Clinsight has been audited by multiple national and international companies.